Unravelling the Mechanisms of Tea Against NAFLD: An Integration of Bibliometrics, Network Pharmacology, and the Gut‐Liver Axis

Non-alcoholic fatty liver disease (NAFLD) represents a significant global health challenge with limited therapeutic options. Tea consumption has emerged as a promising preventive and therapeutic strategy, yet a systematic and integrative understanding of its mechanisms is lacking. This review employs a novel tripartite approach-combining bibliometric analysis, network pharmacology, and an in-depth literature review-to comprehensively elucidate the multi-faceted role of tea in combating NAFLD. The bibliometric analysis identifies 'inflammation,' 'steatosis,' 'insulin resistance,' and 'gut microbiota' as the core research hotspots. Network pharmacology predicts that tea's active constituents target key proteins (e.g., VEGFA, CDK1) to regulate pivotal pathways like P53 and cancer signalling. We further synthesise evidence on how specific components, such as EGCG and yellow tea polysaccharides, modulate pathways including NF-κB and FXR to alleviate oxidative stress, inflammation, and hepatic steatosis. A central mechanistic insight elucidated in this review revolves around the gut-liver axis. We emphasise that despite their low systemic bioavailability, tea polyphenols exert potent prebiotic-like effects. They are metabolised by the gut microbiota into smaller, more bioavailable phenolic acids and other metabolites that retain or even enhance bioactivity. Furthermore, tea polyphenols, polysaccharides, caffeine, and theanine collectively modulate microbial community structure, enhance the production of beneficial metabolites such as short-chain fatty acids, and reinforce intestinal barrier function, thereby collectively ameliorating the progression of NAFLD. This consolidated mechanistic framework not only provides a comprehensive understanding of tea's anti-NAFLD effects but also highlights the significant potential for developing targeted, tea-based nutraceuticals and pharmaceuticals. Moreover, it establishes a scientific basis for guiding scientifically informed tea consumption practices for the management of NAFLD.

Authors

Institutions

Publication Details

Journal
Diabetes/Metabolism Research and Reviews
Published
2025-12-22
DOI
https://doi.org/10.1002/dmrr.70118
Primary Topic
Tea Polyphenols and Effects
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Unravelling the Mechanisms of Tea Against NAFLD: An Integration of Bibliometrics, Network Pharmacology, and the Gut‐Liver Axis

Mengsi Xu, Yi Zheng, Xinyu Wei, Jiali Ren et al.
Diabetes/Metabolism Research and Reviews
Tea Polyphenols and Effects
article

Unravelling the Mechanisms of Tea Against NAFLD: An Integration of Bibliometrics, Network Pharmacology, and the Gut‐Liver Axis

Mengsi Xu, Yi Zheng, Xinyu Wei, Jiali Ren, Xiankuan Li, Tao Jiang, Tianrun Bian, Ying Zhao
article en

Abstract

Non-alcoholic fatty liver disease (NAFLD) represents a significant global health challenge with limited therapeutic options. Tea consumption has emerged as a promising preventive and therapeutic strategy, yet a systematic and integrative understanding of its mechanisms is lacking. This review employs a novel tripartite approach-combining bibliometric analysis, network pharmacology, and an in-depth literature review-to comprehensively elucidate the multi-faceted role of tea in combating NAFLD. The bibliometric analysis identifies 'inflammation,' 'steatosis,' 'insulin resistance,' and 'gut microbiota' as the core research hotspots. Network pharmacology predicts that tea's active constituents target key proteins (e.g., VEGFA, CDK1) to regulate pivotal pathways like P53 and cancer signalling. We further synthesise evidence on how specific components, such as EGCG and yellow tea polysaccharides, modulate pathways including NF-κB and FXR to alleviate oxidative stress, inflammation, and hepatic steatosis. A central mechanistic insight elucidated in this review revolves around the gut-liver axis. We emphasise that despite their low systemic bioavailability, tea polyphenols exert potent prebiotic-like effects. They are metabolised by the gut microbiota into smaller, more bioavailable phenolic acids and other metabolites that retain or even enhance bioactivity. Furthermore, tea polyphenols, polysaccharides, caffeine, and theanine collectively modulate microbial community structure, enhance the production of beneficial metabolites such as short-chain fatty acids, and reinforce intestinal barrier function, thereby collectively ameliorating the progression of NAFLD. This consolidated mechanistic framework not only provides a comprehensive understanding of tea's anti-NAFLD effects but also highlights the significant potential for developing targeted, tea-based nutraceuticals and pharmaceuticals. Moreover, it establishes a scientific basis for guiding scientifically informed tea consumption practices for the management of NAFLD.

Diabetes/Metabolism Research and ReviewsVol. 42(1)
Tianjin University of Traditional Chinese Medicine (CN), First Teaching Hospital of Tianjin University of Traditional Chinese Medicine (CN)
Openalex Percentile: Top 30%
Tea Polyphenols and Effects
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.